Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.

---

Ulas A., Kos T., Avci N., Cubukcu E. , Olmez O. F. , Bulut N., ...More

Asian Pacific journal of cancer prevention : APJCP, vol.16, pp.1643-9, 2015 (Journal Indexed in SCI Expanded)

• Publication Type: Article / Article
• Volume: 16
• Publication Date: 2015
• Doi Number: 10.7314/apjcp.2015.16.4.1643
• Title of Journal : Asian Pacific journal of cancer prevention : APJCP
• Page Numbers: pp.1643-9